Last Posted: Sep 26, 2019
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
H Zhang et al, BiorXIV, September 2019 - Breast Cancer Prognostic Tests: Helping Patients Understand Testing Results and Their Implications.
Miller Lisa et al. Clinical journal of oncology nursing 2019 Oct 23(5) 478-481 - Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini Felipe et al. Breast cancer research : BCR 2019 Sep 21(1) 107 - Population prevalence of individuals meeting criteria for hereditary breast and ovarian cancer testing.
Greenberg Samantha et al. Cancer medicine 2019 Sep - Relationship Between Hereditary Cancer Syndromes and Oncotype DX Recurrence Score.
Casasanta Nicole et al. Clinical breast cancer 2019 Aug - Independent validation of machine learning in diagnosing breast Cancer on magnetic resonance imaging within a single institution.
Ji Yu et al. Cancer imaging : the official publication of the International Cancer Imaging Society 2019 Sep 19(1) 64 - Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients.
Fragoso-Ontiveros Veronica et al. PloS one 2019 14(9) e0222709 - Pathways to breast cancer screening artificial intelligence algorithm validation.
Lee Christoph I et al. Breast (Edinburgh, Scotland) 2019 Sep - Spectrum and prevalence of BRCA1/2 germline mutations in Pakistani breast cancer patients: results from a large comprehensive study.
Rashid Muhammad Usman et al. Hereditary cancer in clinical practice 2019 1727 - Is Everyone Doing Chemo Without Me?
J Wana, NY Times, September 24, 2019
No comments:
Post a Comment